Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2017

High Content & Phenotypic Screening 2017

Date: Tuesday, 25 April 2017 - Wednesday, 26 April 2017
Location: Holiday Inn, Cambridge, UK

Keynote Speakers

Leo Price

Leo Price
CEO, Ocello B.V

Lorenz Mayr

Lorenz Mayr
Vice President, AstraZeneca Ltd

Jeffrey Morgan

Jeffrey Morgan
Professor of Medical Science and Engineering, Brown University


This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

SELECTBIO is offering a limited number of student bursaries at this event. Find out more
Information and local registration facilities for this conference is also available in:

Japanese  |  Korean  |  Chinese(Simplified)  |  Chinese(Traditional)

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 13 April 2017

Agenda Topics

  • High Throughput Screening
  • Image Analysis and Data Management
  • Phenotypic and High Content Screening of 3D Models
  • Phenotypic Drug Discovery
  • Phenotypic Screening for New Targets

Sponsorship and Exhibition Opportunities

Exhibition Team,
+44(0)1787 275645

Confirmed Speakers to date

Chris Bakal, Dynamical Cell Systems Team Leader, Institute of Cancer Research
Alexander Baumann, Senior Director, DiscoveRx Corporation
Stephen Brown, RNAi Facility Screening Manager, Sheffield University
Davide Danovi, Director, Kings College London
Anthony Davies, Director of Translational Cell Imaging, The Queensland University of Technology
Roy Edward, Director, Biostatus Ltd
Catherine Goh, Head of Product Development and Marketing, siTOOLs Biotech GmbH
Kamyar Hadian, Group Leader, Helmholtz Zentrum M√ľnchen
Michael Jackson, Senior Vice President, Drug Discovery and Development, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute
Matthias Nees, Group Leader, University of Turku
Christopher Schofield, Group Leader/Investigator, GlaxoSmithKline
Kevin Smith, Assistant Professor, KTH Royal Institute of Technology
Bob Van de Water, , Leiden University
Armin Wolf, Professor/Director, Novartis Institutes for BioMedical Research
Wolfram-Hubertus Zimmermann, Professor, University Medical Center Goettingen

Corporate Sponsors Media Sponsors Networking

Add to Calendar ▼2017-04-25 00:00:002017-04-26 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2017High Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge,